[1] KARR EMANN M, SAUERBIER J, MEIER C, et al.The impact of prehydration on the clearance and toxicity of high-dose methotrexate for pediatric patients[J]. Leuk Lymphoma, 2014, 55(12): 2874-2878. [2] ZHU H, DENG FY, MO XB, et al.Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update[J]. Pharmacogenomics, 2014, 15(4): 551-566. [3] HOOIJBERG JH, BROXTERMAN HJ, KOOL M, et al.Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2[J]. Cancer Res, 1999, 59(11): 2532-2535. [4] HE HR, LIU P, HE GH, et al.Association between reduced folate carrier G80A polymorphism and methotrexate toxicity in childhood acute lymphoblastic leukemia: a meta-analysis[J]. Leuk Lymphoma, 2014, 55(12): 2793-2800. [5] FAGANEL KB, GRABNAR I, BOHANEC GP, et al.Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma[J]. Eur J Clin Pharmacol, 2011, 67(10): 993-1006. [6] ZGHEIB NK, AKRA-ISMAIL M, ARIDI C, et al.Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia[J]. Pharmacogenet Genomics, 2014, 24(8): 387-396. [7] LOPEZ-LOPEZ E, MARTIN-GUERRERO I, BALLESTEROS J, et al.Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia[J]. Pediatr Blood Cancer, 2011, 57(4): 612-619. [8] ZHU Y, LOU YC, LIU MM, et al.Effect of ABCB13435C>T Genetic polymorphism on plasma concentration and adverse reactions of high-dose methotrexate in acute lymphoblastic leukemia children[J]. China Pharmacist(中国药师), 2017, 20(6): 1058-1061. [9] FAN CY.Association of MTHFR and ABCB1 genetic polymorp-hisms with methotrexate adverse reaction in childhood acute lymphoblastic leukemia[D]. Xinjiang: Xinjiang Medical University(新疆医科大学), 2017. [10] LU AD, ZHANG LP, WANG B, et al.Influence of transport protein gene polymorphisms on the effects and toxicity of high-dose methotrexate in childhood acute lymphoblastic leukemia[J]. J Clin Pediatr(临床儿科杂志), 2013, 31(8): 733-736. [11] WANG SM, SUN LL, ZENG WX.Association between multi- drug resistance 1 C3435T polymorphism with serum concentrations of methotrexate in children with acute lymphoblastic leukemia[J]. Chin J Clin Pharmacol(中国临床药理学杂志), 2012, 28(1): 20-23. [12] GREGERS J, GREEN H, CHRISTENSEN IJ, et al.Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia[J]. Pharmacogenomics J, 2015, 15(4): 372-379. [13] RAMIREZ-PACHECO A, MORENO-GUERRERO S, ALAMILLO I, et al.Mexican childhood acute lymphoblastic leukemia: a pilot study of the mdr1 and mthfr gene polymorphisms and their associations with clinical outcomes[J]. Genet Test Mol Biomarkers, 2016, 20(10): 597-602. [14] LIU SG, GAO C, ZHANG RD, et al.Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia[J]. Oncotarget, 2017, 8(23): 37761-37772. [15] HU C.Association of ATP binding cassette B 1 gene polymorphism in children with acute lymphoblastic leukemia and adverse reaction of high dose methotrexate[D]. Shenyang: China Medical University (中国医科大学), 2017. [16] LIU ST, LI XL, ZHANG Y, et al.Association of ABCBl, ABCC2 and SLCO1B1 gene polymorphisms with toxicity response of high dose methotrexate chemotherapy[J]. Chin J Lab Med(中华检验医学杂志), 2014, 37(1): 60-65. [17] JING R.The application of mtx related drug gene polymorphism in children with acute lymphoblastic leukemia[D]. Jinan: Shandong University(山东大学), 2018. [18] CHEOK MH, POTTIER N, KAGER L, et al.Pharmacogenetics in acute lymphoblastic leukemia[J]. Semin Hematol, 2009, 46(1): 39-51. [19] HAMIDOVIC A, HAHN K, KOLESAR J.Clinical significance of ABCB1 genotyping in oncology[J]. J Oncol Pharm Pract, 2010, 16(1): 39-44. [20] WANG Z, ZHOU Q, KRUH G D, et al.Dose-dependent disposition of methotrexate in Abcc2 and Abcc3 gene knockout murine models[J]. Drug Metab Dispos, 2011, 39(11): 2155-2161. [21] VAN DE STEEG E, VAN DER KRUIJSSEN CM, WAGENAAR E, et al. Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic anion-transporting polypeptide 1B1 (SLCO1B1)[J]. Drug Metab Dispos, 2009, 37(2): 277-281. |